Search NASA⌕ Search

SEARCH · Search NASA

Results for “LUTETIUM 168”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

Nuclear Data Sheets for A = 168

Nuclear structure data pertaining to all nuclei with mass A=168 (Tb, Dy, Ho, Er, Tm, Yb, Lu, Hf, Ta, W, Re, Os, Ir, Pt) have been evaluated and incorporated into the ENSDF data file. This evaluation supersedes the previous publication (V.S. Shirley, Nuclear Data Sheets 71, 261 (1994) (literature cutoff date July 1993)) and subsequent ENSDF file revisions for Tb and Dy (C. Baglin, literature cutoff date of 15 June 1999) and Hf (B. Singh, literature cutoff date of 30 April 2001), and includes literature available by 15 June 2010. Since the above evaluations, the first excited states in {sup 168}Pt have been identified (1998Ki20, 2009Go16) and {alpha} decay from {sup 172}Hg has been observed (2009Sa27, 2004Ke06, 1999Se14). New levels in {sup 168}Dy have been excited using the {sup 170}Er({sup 82}Se,{sup 84}Kr{gamma}) reaction (2010So03). (HI,xn{gamma}) studies have significantly expanded our knowledge of level structure in {sup 168}Lu (1999Ka17, 2002Ha33), {sup 168}Ta (2008QiZZ), {sup 168}Yb (1995Fi01), {sup 168}Tm (2007CaZW), {sup 168}Hf (2009Ya21), {sup 168}Os (2001Jo11, 2009Od02) and, for {sup 168}Tm, important information has come also from (d,2n{gamma}) and ({alpha},n{gamma}) reactions (1995Si20). Revised decay schemes are available following new studies of {sup 168}Hf {epsilon} decay (6.7 min) (1997Ba26), {sup 168}Lu {epsilon} decay (1999Ba65), {sup 168}Ta {epsilon} decay (2007Mc08) and {sup 172}Au {alpha} decay (2009Ha42). Significant new information for {sup 168}Er is available from (p,t) (2006Bu09), (d,p) and (t,d) (1996Ma50), ({gamma},{gamma}') (1996Ma18), (136Xe, X{gamma}) (2010Dr02), ({sup 238}U,{sup 238}U{sup '{gamma}}) (2003Wu07) and (n,n{sup '{gamma}}) (1998Be20, 1998Be62) reactions, and the availability of {gamma}{gamma} coin data (1994Ju02, 1996Gi09) for the (n,{gamma}) E=thermal reaction has resulted in some significant level scheme revisions.

73 NUCLEAR PHYSICS AND RADIATION PHYSICS↗

Cross section for inelastic neutron ''acceleration'' by {sup 178}Hf{sup m2}

The scattering of thermal neutrons from isomeric nuclei may include events in which the outgoing neutrons have increased kinetic energy. This process has been called inelastic neutron acceleration, or INNA, and occurs when the final nucleus, after emission of the neutron, is left in a state with lower energy than that of the isomer. The result, therefore, is an induced depletion of the isomer to the ground state. A cascade of several {gamma}'s must accompany the neutron emission to release the high angular momentum of the initial isomeric state. INNA was previously observed in a few cases, and the measured cross sections were only in modest agreement with theoretical estimates. The most recent measurement of an INNA cross section was {sigma}{sub INNA}=258{+-}58 b for neutron scattering by {sup 177}Lu{sup m}. In the present work, an INNA cross section of {sigma}{sub INNA}=168 {+-} 33 b was deduced from measurements of the total burnup of the high-spin, four-quasiparticle isomer {sup 178}Hf{sup m2} during irradiation by thermal neutrons. Statistical estimates for the probability of different reaction channels past neutron absorption were used in the analysis, and the deduced {sigma}{sub INNA} was compared to the theoretically predicted cross section.

73 NUCLEAR PHYSICS AND RADIATION PHYSICS↗

SU-G-IeP4-05: Experience with a Practical Approach to the Release of Radioactive Patients from Radiation Safety Isolation

Purpose: The radioactive patient releases of the nuclear medicine department in a large cancer center were analyzed to compare the estimated doses to others to the regulatory limit and institutional targets and to gauge how onerous the patients’ instructions were. Methods: In-house software that implements the NUREG 1556 approach and further considers fellow travelers, children and pregnant women and members of the public following Siegel, et al., is used to calculate release timing and to provide patients with individualized instructions. A retrospective analysis of the 218 releases in 2015 that required instructions included all I-131 and Lu-177 treatments. Results: There were 87 male and 131 female patients. They were 45.5±16.5 (8-84) years old, weighed 83.3±21.8 kg and stood 168±10 cm tall with a body mass index of 29.3±6.7 kg/m2. 195 patients received 2.96±2.23 GBq of I-131-NaI for differentiated thyroid carcinoma and eight received 636±231 MBq of I-131-NaI for hyperthyroidism. There were eight administrations of 18.5 GBq of I-131-mIBG and seven administrations of 7.4 GBq of Lu-177-DOTATATE. The dose to the most exposed person was 1.67±1.05 (mode=0.60, median=1.15) mSv. The dose to a fellow traveler was 0.31±0.31 (mode=0.1, median=0.17) mSv. The dose to children and pregnant women was 0.51±0.34 (mode=1.0, median=0.42) mSv. The duration of isolation was 7.7±17.3 (mode=2, median=1.7) hours. The duration of sleeping alone was 60.4±127 (mode=0, median=15.5) hours. The time to delay traveling was 12.2±11 (mode=median=0) hours. The time to completely avoid children and pregnant women was 23.3±26.5 (0–254, mode=median=24) hours followed by limited contact for 20.6±68.1 (0–491, mode=median=0) hours. The time to avoid others (e.g., to wait to return to work) was 12.1±101 (0–1465, mode=median=0) hours. Conclusion: The estimated doses to others were often well below the limits set by regulation, 5 mSv, or prudent practice, 1 mSv. Most patients’ instructions were not hard to comply with.

60 APPLIED LIFE SCIENCES↗